Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement
NEW YORK and SOUTH SAN FRANCISCO, Calif., June 13, 2022 /PRNewswire/ — Biotech Acquisition Company (NASDAQ: BIOT) (“BAC”), a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, and Blade Therapeutics, Inc. (“Blade”), a biopharmaceutical company…
Comments Off on Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement